WEBULL
WebtradeDownload

Scotts Miracle Gro (SMG) Stock Price Reflects Debt Fears Over Margin Gains

Simply Wall St · 1d ago

Scotts Miracle-Gro slipped almost 3% to about US$68 on Wednesday, yet the earnings story is less about a stumble and more about a balance sheet gut check. The market fixated on the headline move, while the more important signal sits in the mix of modest Q3 revenue of US$1,172.1m and higher trailing profit margins, set against a capital structure that still carries heavy debt.

For you as an investor, today was about a sentiment reset. The stock came in with a solid 90 day run and a discounted cash flow value well above the share price. The headline from this quarter is pressure on the balance sheet and dividend coverage, even as profitability metrics look cleaner than a year ago.

Is Scotts Miracle-Gro trading at a genuine discount to its estimated fair value, or is the weak dividend cover and heavy debt load doing more damage than the headline P/E suggests? Compare the implied upside, debt risks, and cash flow assumptions directly in our valuation analysis for Scotts Miracle-Gro

Q3 2026 Earnings Summary

  • Revenue (Q3 2026 vs Q3 2025): US$1,172.1m vs. US$1,188.0m (slight decline in quarterly revenue for Scotts Miracle-Gro)
  • Net Income (Excl. Extra Items, Q3 2026 vs Q3 2025): US$103.6m vs. US$149.1m (fell about 30.5%)
  • Basic EPS (Q3 2026 vs Q3 2025): US$1.78 vs. US$2.58 (fell about 31.0%)
  • Trailing 12 Month Net Profit Margin (Q3 2026 vs prior year): 4.4% vs. 1.8% (margin level more than doubled over the year)

Prefer clean visuals instead of another wall of earnings tables and balance sheet figures? Get a full picture of Scotts Miracle-Gro with a clear view of its debt load and balance sheet strength in the company report for Scotts Miracle-Gro.

NYSE:SMG Trailing 12-Month Revenue & Expenses Breakdown as at Jul 2026
NYSE:SMG Trailing 12-Month Revenue & Expenses Breakdown as at Jul 2026

Scotts Miracle-Gro bull case meets mixed execution

Bulls argue Scotts Miracle-Gro is becoming a higher quality supplier to controlled environment and semi professional growers, with more durable earnings than a seasonal lawn and garden business. The latest numbers partially support that. Branded products grew 4.5% year to date and new products from the last three years added about US$278m, which points to traction in more technical, higher margin lines. Gross margin year to date improved to 35.7% and non GAAP EBITDA rose 5%, which aligns with the focus on quality earnings and cost out. E commerce now accounts for roughly 13% of point of sale, so the push into digital channels is clearly moving. That said, Q3 gross margin eased to 31.2% due to freight and commodity costs and net income for the quarter declined versus last year, showing the premium supplier narrative is not yet fully insulated from basic cost shocks.

Debt, cannabis risk and governance still weigh on SMG

The bear story focuses on heavy debt, cannabis volatility and governance overhangs that could cap investor confidence. This quarter does not erase those concerns. Leverage improved to 3.78x from 4.15x and free cash flow is being used to pay debt down, but management is still targeting leverage below 3.5x, which signals the balance sheet remains a work in progress. Q3 adjusted EBITDA fell versus last year due to freight and commodity pressure, which shows operating momentum can still be fragile. Management reaffirmed guidance and lifted non GAAP EPS expectations, yet the stock fell about 2.9% on the day, suggesting investors remain cautious. Legal investigations around past disclosures are still open and cannabis exposure is still described as a risk rather than a clear growth driver. The decision to start share repurchases alongside a stretched balance sheet also keeps the capital allocation debate alive.

Compare how Scotts Miracle-Gro talks about margin progress and product traction with what the street actually expects. See the consensus price target analysis for Scotts Miracle-Gro to check whether analysts think this reset after a 2.9% drop is the start of a rerating or just a pause.

Stay Ahead With Simply Wall St

If the mix of cleaner margins, heavy debt and dividend pressure around Scotts Miracle-Gro has your attention, register free with Simply Wall St and add it to a Watchlist to keep an eye on price moves against fair value estimates and wait for a setup that fits your plan. Once you own Scotts Miracle-Gro or any other stock, organise everything in one place with the Portfolio Command Center that cuts through noise and highlights the updates that matter most. For the longer journey, compare your thinking with thousands of other investors through the Community and see different angles on the same set of numbers. By spotting potential catalysts and risks early, you give yourself a better chance of staying ahead of the market rather than reacting to it late.

Seeking Fresh Alternatives Beyond Scotts Miracle-Gro

Some stocks are already building quiet breakout momentum while others are still flying under the radar for now. Before the best entry points get caught, consider researching potential opportunities sooner rather than later.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.